← Eichor
Condition: Albuminuria Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Albuminuria

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Alb
Phase 2 · 71 location(s) · AstraZeneca · NCT07222917A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Phase 2 · 79 location(s) · Maze Therapeutics · NCT06830629Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa
Phase N/A · 1 location(s) · Swiss Tropical & Public Health Institute · NCT05881447Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
Phase 2 · 1 location(s) · University of Illinois at Chicago · NCT07175051ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases
Phase 4 · 1 location(s) · Ace Cells Lab Limited · NCT07187713The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study
Phase 2 · 1 location(s) · University of North Carolina, Chapel Hill · NCT06059664Hypertension in Children and Young People at Risk of Autosomal Dominant Polycystic Kidney Disease
Phase N/A · 1 location(s) · King's College London · NCT07260071The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease
Phase 2 · 1 location(s) · National Taiwan University Hospital · NCT06528405Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Dise
Phase 4 · 1 location(s) · Centenario Hospital Miguel Hidalgo · NCT07405216PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a National Cros
Phase N/A · 27 location(s) · Beijing Anzhen Hospital · NCT06336239Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes
Phase 4 · 1 location(s) · University of Colorado, Denver · NCT05498116Effect Camostat for Kidney Protection in Chronic Kidney Disease
Phase 2 · 1 location(s) · Odense University Hospital · NCT06794593Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors
Phase N/A · 13 location(s) · Herlev Hospital · NCT04916132Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome
NA · 1 location(s) · Universidade do Porto · NCT07173062Time-restricted Eating in Patients With Moderate Chronic Kidney Disease and Albuminuria
NA · 1 location(s) · de Seigneux Sophie · NCT06618859The Evaluation of the Drug R3R01 for the Excretion of Protein in the Urine in Patients With Diabetic Kidney Disease.
Phase 2 · 1 location(s) · River 3 Renal Corp. · NCT06600412Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
Phase N/A · 1 location(s) · Wake Forest University Health Sciences · NCT04752293Single and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fra
Phase 4 · 1 location(s) · Evi Liliek Wulandari · NCT07259512
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.